Cell Therapy Manufacturing & Gene Therapy Congress
December 04, 2018 ‐ December 06, 2018 in Amsterdam, Netherlands
The Cell Therapy Manufacturing & Gene Therapy Congress will be held from December 4 to 6, 2018 in Amsterdam, Netherlands.
David Sourdive, Ph.D., Executive Vice President Technical, and Robert Leach, Ph.D., Quality Control Manager, to take part in this event.
David Sourdive will give a presentation entitled "Transforming cell therapy with gene editing: the case of “off-the-shelf” engineered CAR-T in the clinic" on December the 4th from 4:30 PM to 5:05 PM.
Robert Leach will give a presentation entitled "Meeting the challenge of delivering allogeneic therapies in the commercial sector" on December the 5th from 4:00 PM to 4:35 PM.